ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in Madrid, MD

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Type 2 Diabetes Mellitus
Diabetes Mellitus
Obesity
Type 1 Diabetes Mellitus
Diabetic Foot
Foot Ulcer
Overweight

Diabetes trials near Madrid, MD, ESP:

EFFICACY OF REMOTE MONITORING OF PATIENTS WITH DIABETES UNDER INSULIN TREATMENT, BY USING Caaring SOFTWARE (GluCaaring)

The goal of this clinical trial investigation with device is to determinate the efficacy of the remote monitoring in insulin-treated diabetic...

Enrolling
Diabetes Mellitus
Device: software
Persei Vivarium

Madrid, Spain and 1 other location

The objective of DIAGNODE-3 is to evaluate the efficacy and safety of three intranodal injections of 4 μg of Diamyd compared to placebo, along with o...

Enrolling
Type 1 Diabetes Mellitus
Biological: Recombinant human glutamic acid decarboxylase (rhGAD65) formulated in Alhydrogel®
Biological: Placebo

Phase 3

Diamyd Medical

Madrid, Spain and 59 other locations

This study will look at the effects of CagriSema in people with both type 2 diabetes and painful diabetic peripheral neuropathy, co...

Active, not recruiting
Diabetes Mellitus, Type 2
Diabetic Peripheral Neuropathy
Drug: CagriSema (Cagrilintide B and Semaglutide I)
Drug: Placebo matched to CagriSema (Cagrilintide B and Semaglutide I)

Phase 2

Novo Nordisk
Novo Nordisk

Madrid, Spain and 54 other locations

double-blind, parallel-group, placebo-controlled study to evaluate the efficacy, safety and tolerability of AZD5004 in adults with type 2 diabetes...

Active, not recruiting
Diabetes Mellitus, Type 2
Drug: AZD5004
Drug: Placebo (placebo matching AZD5004 film-coated tablet)

Phase 2

AstraZeneca
AstraZeneca

Madrid, Spain and 96 other locations

Status recently updated

the efficacy and safety of eloralintide compared with placebo for body weight reduction in participants with overweight or obesity and type 2 diabetes...

Not yet enrolling
Enrolling
Overweight
Obesity
Drug: Eloralintide
Drug: Placebo

Phase 3

Lilly
Lilly

Madrid, Spain and 158 other locations

The purpose of this study is to find out if baricitinib can delay the onset of clinical type 1 diabetes (T1D) in people who are at high risk...

Begins enrollment this month
Diabetes Mellitus, Type 1
Drug: Baricitinib
Drug: Placebo

Phase 3

Lilly
Lilly

Madrid, Spain and 107 other locations

The main purpose of this study is to find out how well and how safely tirzepatide works long-term in adults who have type 1 diabetes and obe...

Enrolling
Type 1 Diabetes
Overweight
Drug: Placebo
Drug: Tirzepatide

Phase 3

Lilly
Lilly

Madrid, Spain and 78 other locations

Locations recently updated

The purpose of this study is to find out if baricitinib can preserve beta-cell function in participants newly diagnosed with type 1 diabetes...

Begins enrollment in 2 months
Diabetes Mellitus, Type 1
Drug: Baricitinib
Drug: Placebo

Phase 3

Lilly
Lilly

Madrid, Spain and 126 other locations

Locations recently updated

Phase II study aims to evaluate the efficacy, tolerability, and safety of RO7795081 for glycemic control in adult participants with Type 2 diabetes...

Enrolling
Type 2 Diabetes Mellitus
Drug: Semaglutide
Drug: Placebo

Phase 2

Roche
Roche

Madrid, Spain and 49 other locations

The purpose of this study is to is to evaluate the efficacy and safety of retatrutide in participants with type 2 diabetes in participants w...

Active, not recruiting
Type 2 Diabetes
Overweight
Drug: Placebo
Drug: Retatrutide

Phase 3

Lilly
Lilly

Madrid, Madrid, Comunidad De, Spain and 99 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems